Scrutinizing Scientific Funding and Bioweapons

This chapter critiques the inefficiencies in scientific research funding, focusing on bioweapons laboratories and their ties to pharmaceutical companies. It highlights the urgency for accountability and transparency in the wake of COVID-19 and anticipates significant upcoming testimonies that could reshape established narratives.